Back to search

Article

Luliconazole, a New Antifungal, vs Amphotericin B, Voriconazole, Posaconazole and Caspofungin against Clinical and Environmental <i>Aspergillus</i> Nigri Complex

2019-02-05

Abstract excerpt

<h4>ABSTRACT</h4> Black Aspergilli are, the most causes of aspergillosis and Aspergillus niger and A. tubingensis are two more frequently isolates. Although, amphotericin B was a gold standard for the treatment of invasive fungal infection for several decades, it replaced by several new antifungals. Furthermore, a novel antifungal, luliconazole, appears to offer the potential for improved therapy for aspergillos...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
abe1550a-d2ca-5686-97bb-aa865e6b89d4
DOI
10.1101/541185
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Luliconazole, a New Antifungal, vs Amphotericin B, Voriconazole, Posaconazole and Caspofungin against Clinical and Environmental <i>Aspergillus</i> Nigri ComplexDOI 10.1101/541185
Select a neighboring publication to make it the new centre.